{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:11:46Z","timestamp":1792951906960,"version":"4.5.0"},"reference-count":184,"publisher":"Harborside Press, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel\u2019s most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.<\/jats:p>","DOI":"10.6004\/jnccn.2022.0016","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T16:27:52Z","timestamp":1647016072000},"page":"224-234","source":"Crossref","is-referenced-by-count":494,"title":["NCCN Guidelines\u00ae Insights: Head and Neck Cancers, Version 1.2022"],"prefix":"10.6004","volume":"20","author":[{"given":"Jimmy J.","family":"Caudell","sequence":"first","affiliation":[{"name":"1Moffitt Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura L.","family":"Gillison","sequence":"additional","affiliation":[{"name":"2The University of Texas MD Anderson Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Maghami","sequence":"additional","affiliation":[{"name":"3City of Hope National Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Spencer","sequence":"additional","affiliation":[{"name":"4O'Neal Comprehensive Cancer Center at UAB;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Pfister","sequence":"additional","affiliation":[{"name":"5Memorial Sloan Kettering Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Adkins","sequence":"additional","affiliation":[{"name":"6Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Birkeland","sequence":"additional","affiliation":[{"name":"7UC Davis Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Brizel","sequence":"additional","affiliation":[{"name":"8Duke Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Busse","sequence":"additional","affiliation":[{"name":"9Massachusetts General Hospital Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Cmelak","sequence":"additional","affiliation":[{"name":"10Vanderbilt-Ingram Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Dimitrios","family":"Colevas","sequence":"additional","affiliation":[{"name":"11Stanford Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Eisele","sequence":"additional","affiliation":[{"name":"12The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Galloway","sequence":"additional","affiliation":[{"name":"13Fox Chase Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Geiger","sequence":"additional","affiliation":[{"name":"14Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I.","family":"Haddad","sequence":"additional","affiliation":[{"name":"15Dana-Farber\/Brigham and Women\u2019s Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley L.","family":"Hicks","sequence":"additional","affiliation":[{"name":"16Roswell Park Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying J.","family":"Hitchcock","sequence":"additional","affiliation":[{"name":"17Huntsman Cancer Institute at the University of Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Jimeno","sequence":"additional","affiliation":[{"name":"18University of Colorado Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Leizman","sequence":"additional","affiliation":[{"name":"14Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren K.","family":"Mell","sequence":"additional","affiliation":[{"name":"19UC San Diego Moores Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat B.","family":"Mittal","sequence":"additional","affiliation":[{"name":"20Robert H. Lurie Comprehensive Cancer Center of Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan A.","family":"Pinto","sequence":"additional","affiliation":[{"name":"11Stanford Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Rocco","sequence":"additional","affiliation":[{"name":"21The Ohio State University Comprehensive Cancer Center \u2013 James Cancer Hospital and Solove Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina P.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"22Fred Hutchinson Cancer Research Center\/Seattle Cancer Care Alliance;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis S.","family":"Savvides","sequence":"additional","affiliation":[{"name":"23Mayo Clinic Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schwartz","sequence":"additional","affiliation":[{"name":"24St. Jude Children\u2019s Research Hospital\/The University of Tennessee Health Science Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin P.","family":"Shah","sequence":"additional","affiliation":[{"name":"5Memorial Sloan Kettering Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sher","sequence":"additional","affiliation":[{"name":"25UT Southwestern Simmons Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maie","family":"St. John","sequence":"additional","affiliation":[{"name":"26UCLA Jonsson Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal S.","family":"Weber","sequence":"additional","affiliation":[{"name":"2The University of Texas MD Anderson Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Weinstein","sequence":"additional","affiliation":[{"name":"27Abramson Cancer Center at the University of Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Worden","sequence":"additional","affiliation":[{"name":"28University of Michigan Rogel Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Yang Bruce","sequence":"additional","affiliation":[{"name":"29University of Wisconsin Carbone Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue S.","family":"Yom","sequence":"additional","affiliation":[{"name":"30UCSF Helen Diller Family Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weining","family":"Zhen","sequence":"additional","affiliation":[{"name":"31Fred & Pamela Buffett Cancer Center; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Burns","sequence":"additional","affiliation":[{"name":"32National Comprehensive Cancer Network."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Darlow","sequence":"additional","affiliation":[{"name":"32National Comprehensive Cancer Network."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"ref151","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12905-020-01035-0","article-title":"Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil","volume":"20","author":"da Silva","year":"2020","journal-title":"BMC Womens Health"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of de-intensified chemoradiotherapy for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref1791","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.19.00370","article-title":"Evolution of the oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals","volume":"37","author":"Tota","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hed.21669","article-title":"Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study","volume":"33","author":"Haughey","year":"2011","journal-title":"Head Neck"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1200\/JCO.2016.66.6081","article-title":"Human papillomavirus and oropharyngeal cancer stage","volume":"34","author":"Gillison","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref1451","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semradonc.2012.03.003","article-title":"Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer","volume":"22","author":"Mehra","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hed.23136","article-title":"Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia","volume":"34","author":"Adelstein","year":"2012","journal-title":"Head Neck"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ijc.30516","article-title":"Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis","volume":"140","author":"Prigge","year":"2017","journal-title":"Int J Cancer"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cncr.30954","article-title":"Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: findings from a phase 2 trial","volume":"124","author":"Hegde","year":"2018","journal-title":"Cancer"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2019.10.011","article-title":"Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification","volume":"144","author":"Huang","year":"2020","journal-title":"Radiother Oncol"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hed.23850","article-title":"HPV-related oropharyngeal cancer: risk factors for treatment failure in patients managed with primary transoral robotic surgery","volume":"38","author":"Kaczmar","year":"2016","journal-title":"Head Neck"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref1531","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/lary.23900","article-title":"Margin mapping in transoral surgery for head and neck cancer","volume":"123","author":"Hinni","year":"2013","journal-title":"Laryngoscope"},{"key":"ref1141","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/cncr.29938","article-title":"Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base","volume":"122","author":"Cracchiolo","year":"2016","journal-title":"Cancer"},{"key":"ref1511","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00405-013-2603-0","article-title":"New treatment strategies for HPV-positive head and neck cancer","volume":"271","author":"Kofler","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"138469","DOI":"10.4061\/2011\/138469","article-title":"Ancillary studies in determining human papillomavirus status of squamous cell carcinoma of the oropharynx: a review","volume":"2011","author":"Cantley","year":"2011","journal-title":"Pathol Res Int"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1200\/JCO.2016.66.6081","article-title":"Human papillomavirus and oropharyngeal cancer stage","volume":"34","author":"Gillison","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN Cancer Research Group","volume":"35","author":"Marur","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamaoncol.2015.5504","article-title":"Associations of oral alpha-, beta-, and gamma-human papillomavirus types with risk of incident head and neck cancer","volume":"2","author":"Agalliu","year":"2016","journal-title":"JAMA Oncol"},{"key":"ref1181","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdr006","article-title":"Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial","volume":"22","author":"Posner","year":"2011","journal-title":"Ann Oncol"},{"key":"ref1441","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/cncr.32799","article-title":"Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer","volume":"126","author":"Lang Kuhs","year":"2020","journal-title":"Cancer"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hed.21669","article-title":"Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study","volume":"33","author":"Haughey","year":"2011","journal-title":"Head Neck"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/ijc.32164","article-title":"Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region","volume":"145","author":"Ren","year":"2019","journal-title":"Int J Cancer"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/ijc.32164","article-title":"Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region","volume":"145","author":"Ren","year":"2019","journal-title":"Int J Cancer"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejca.2018.08.015","article-title":"Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications","volume":"103","author":"Lu","year":"2018","journal-title":"Eur J Cancer"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/cncr.28169","article-title":"Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status","volume":"119","author":"Maxwell","year":"2013","journal-title":"Cancer"},{"key":"ref1851","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2020.01.005","article-title":"Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome","volume":"143","author":"Deschuymer","year":"2020","journal-title":"Radiother Oncol"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.20.00056","article-title":"De-escalation after DE-ESCALATE and RTOG 1016: a Head and Neck Cancer InterGroup Framework for future de-escalation studies","volume":"38","author":"Mehanna","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref651","author":"Palma","journal-title":"A phase II randomized trial of treatment de-escalation for HPV associated oropharyngeal squamous cell carcinoma: radiotherapy vs trans-oral surgery (ORATOR 2)"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jcp.2010.088450","article-title":"Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice","volume":"64","author":"Thavaraj","year":"2011","journal-title":"J Clin Pathol"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1158\/1078-0432.CCR-06-1690","article-title":"Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck","volume":"13","author":"Begum","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.oraloncology.2009.11.004","article-title":"Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer","volume":"46","author":"D\u2019Souza","year":"2010","journal-title":"Oral Oncol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","article-title":"HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis","volume":"15","author":"Ndiaye","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial","volume":"28","author":"Rischin","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jcp.2010.088450","article-title":"Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice","volume":"64","author":"Thavaraj","year":"2011","journal-title":"J Clin Pathol"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","article-title":"Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?","volume":"125","author":"N\u00e4sman","year":"2009","journal-title":"Int J Cancer"},{"key":"ref1611","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/cncr.31338","article-title":"Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"124","author":"Chera","year":"2018","journal-title":"Cancer"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/lary.23493","article-title":"Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer","volume":"122","author":"Haughey","year":"2012","journal-title":"Laryngoscope"},{"key":"ref1691","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejca.2018.08.015","article-title":"Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications","volume":"103","author":"Lu","year":"2018","journal-title":"Eur J Cancer"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.2015.64.6448","article-title":"Proposed staging system for patients with HPV-related oropharyngeal cancer based on nasopharyngeal cancer N categories","volume":"34","author":"Dahlstrom","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States","volume":"26","author":"Chaturvedi","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00405-015-3728-0","article-title":"Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status","volume":"273","author":"Coordes","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gr.241141.118","article-title":"Human papillomavirus and the landscape of secondary genetic alterations in oral cancers","volume":"29","author":"Gillison","year":"2019","journal-title":"Genome Res"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.2012.46.7746","article-title":"Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?","volume":"31","author":"Quon","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gr.241141.118","article-title":"Human papillomavirus and the landscape of secondary genetic alterations in oral cancers","volume":"29","author":"Gillison","year":"2019","journal-title":"Genome Res"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1470-2045(17)30246-2","article-title":"Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study","volume":"18","author":"Chen","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref1751","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/cncr.32667","article-title":"Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma","volume":"126","author":"Freitag","year":"2020","journal-title":"Cancer"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3201\/eid2005.131311","article-title":"Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States","volume":"20","author":"Steinau","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.oraloncology.2015.02.098","article-title":"High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer","volume":"51","author":"Sinha","year":"2015","journal-title":"Oral Oncol"},{"key":"ref1571","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial [published online January 7, 2022]","author":"Nichols","journal-title":"J Clin Oncol"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.19.00463","article-title":"Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma","volume":"37","author":"Ma","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1200\/JCO.2011.38.4099","article-title":"Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer","volume":"30","author":"Gillison","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hed.21997","article-title":"Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status","volume":"34","author":"Spector","year":"2012","journal-title":"Head Neck"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdr006","article-title":"Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial","volume":"22","author":"Posner","year":"2011","journal-title":"Ann Oncol"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","article-title":"Randomized trial of radiation therapy with weekly cisplatin or cetuximab in low-risk HPV-associated oropharyngeal cancer (TROG 12.01)\u2014a Trans-Tasman Radiation Oncology Group Study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0b013e3181f895c1","article-title":"Human papillomavirus detection in head and neck squamous cell carcinomas","volume":"17","author":"Snow","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1158\/1078-0432.CCR-06-1690","article-title":"Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck","volume":"13","author":"Begum","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.oraloncology.2009.11.004","article-title":"Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer","volume":"46","author":"D\u2019Souza","year":"2010","journal-title":"Oral Oncol"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2017.10.018","article-title":"Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: the MARCH-HPV project","volume":"126","author":"Lassen","year":"2018","journal-title":"Radiother Oncol"},{"key":"ref1721","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.oraloncology.2015.02.098","article-title":"High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer","volume":"51","author":"Sinha","year":"2015","journal-title":"Oral Oncol"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2020.01.005","article-title":"Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome","volume":"143","author":"Deschuymer","year":"2020","journal-title":"Radiother Oncol"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"e0203403","DOI":"10.1371\/journal.pone.0203403","article-title":"Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer","volume":"13","author":"LeConte","year":"2018","journal-title":"PLoS One"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O\u2019Sullivan","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7785\/tcrt.2012.500305","article-title":"Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis","volume":"12","author":"Al-Mamgani","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/cncr.32652","article-title":"Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status","volume":"126","author":"Fullerton","year":"2020","journal-title":"Cancer"},{"key":"ref1501","first-page":"CD010271","article-title":"De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"2","author":"Masterson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1245\/s10434-015-4525-0","article-title":"Detailed analysis of clinicopathologic factors demonstrate distinct difference in outcome and prognostic factors between surgically treated HPV-positive and negative oropharyngeal cancer","volume":"22","author":"Iyer","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/cncr.32667","article-title":"Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma","volume":"126","author":"Freitag","year":"2020","journal-title":"Cancer"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009-2010","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.otc.2012.04.006","article-title":"Transoral endoscopic surgery: new surgical techniques for oropharyngeal cancer","volume":"45","author":"Li","year":"2012","journal-title":"Otolaryngol Clin North Am"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","article-title":"Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?","volume":"125","author":"N\u00e4sman","year":"2009","journal-title":"Int J Cancer"},{"key":"ref641","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial [published online January 7, 2022]","author":"Nichols","journal-title":"J Clin Oncol"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ijc.30516","article-title":"Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis","volume":"140","author":"Prigge","year":"2017","journal-title":"Int J Cancer"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1245\/s10434-015-4525-0","article-title":"Detailed analysis of clinicopathologic factors demonstrate distinct difference in outcome and prognostic factors between surgically treated HPV-positive and negative oropharyngeal cancer","volume":"22","author":"Iyer","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"ref1621","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of de-intensified chemoradiotherapy for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/cncr.26671","article-title":"Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma","volume":"118","author":"Sinha","year":"2012","journal-title":"Cancer"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/annonc\/mdu265","article-title":"The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck","volume":"25","author":"Psyrri","year":"2014","journal-title":"Ann Oncol"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamaoncol.2015.5504","article-title":"Associations of oral alpha-, beta-, and gamma-human papillomavirus types with risk of incident head and neck cancer","volume":"2","author":"Agalliu","year":"2016","journal-title":"JAMA Oncol"},{"key":"ref1411","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hed.23850","article-title":"HPV-related oropharyngeal cancer: risk factors for treatment failure in patients managed with primary transoral robotic surgery","volume":"38","author":"Kaczmar","year":"2016","journal-title":"Head Neck"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"ref1561","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/cncr.25033","article-title":"Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience","volume":"116","author":"Singhi","year":"2010","journal-title":"Cancer"},{"key":"ref1741","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/lary.23493","article-title":"Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer","volume":"122","author":"Haughey","year":"2012","journal-title":"Laryngoscope"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009-2010","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/cncr.28169","article-title":"Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status","volume":"119","author":"Maxwell","year":"2013","journal-title":"Cancer"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-43580-0_20","article-title":"Update on de-intensification and intensification studies in HPV","volume":"206","author":"Mehanna","year":"2017","journal-title":"Recent Results Cancer Res"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"E805","DOI":"10.1002\/hed.24105","article-title":"Matted nodes: high distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer","volume":"38","author":"Vainshtein","year":"2016","journal-title":"Head Neck"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","article-title":"Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis","volume":"30","author":"Gillison","year":"2012","journal-title":"Vaccine"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","article-title":"Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis","volume":"30","author":"Gillison","year":"2012","journal-title":"Vaccine"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.2004.00.3335","article-title":"Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis","volume":"24","author":"Weinberger","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref1641","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hed.21997","article-title":"Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status","volume":"34","author":"Spector","year":"2012","journal-title":"Head Neck"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.2019.10508","article-title":"Prevalence of oral HPV infection in unvaccinated men and women in the United States, 2009-2016","volume":"322","author":"Chaturvedi","year":"2019","journal-title":"JAMA"},{"key":"ref1551","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/cncr.29938","article-title":"Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base","volume":"122","author":"Cracchiolo","year":"2016","journal-title":"Cancer"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0b013e3181f895c1","article-title":"Human papillomavirus detection in head and neck squamous cell carcinomas","volume":"17","author":"Snow","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.2004.00.3335","article-title":"Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis","volume":"24","author":"Weinberger","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/cncr.30598","article-title":"The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"123","author":"An","year":"2017","journal-title":"Cancer"},{"key":"ref1541","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.otc.2012.04.006","article-title":"Transoral endoscopic surgery: new surgical techniques for oropharyngeal cancer","volume":"45","author":"Li","year":"2012","journal-title":"Otolaryngol Clin North Am"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00405-013-2603-0","article-title":"New treatment strategies for HPV-positive head and neck cancer","volume":"271","author":"Kofler","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN Cancer Research Group","volume":"35","author":"Marur","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"ref1461","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/annonc\/mdu265","article-title":"The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck","volume":"25","author":"Psyrri","year":"2014","journal-title":"Ann Oncol"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.2015.64.6448","article-title":"Proposed staging system for patients with HPV-related oropharyngeal cancer based on nasopharyngeal cancer N categories","volume":"34","author":"Dahlstrom","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref1131","first-page":"108","article-title":"Multisite HPV16\/18 vaccine efficacy against cervical, anal, and oral HPV infection","volume":"108","author":"Beachler","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"ref1831","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7785\/tcrt.2012.500305","article-title":"Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis","volume":"12","author":"Al-Mamgani","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O\u2019Sullivan","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12905-020-01035-0","article-title":"Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil","volume":"20","author":"da Silva","year":"2020","journal-title":"BMC Womens Health"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3201\/eid2005.131311","article-title":"Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States","volume":"20","author":"Steinau","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2017.10.018","article-title":"Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: the MARCH-HPV project","volume":"126","author":"Lassen","year":"2018","journal-title":"Radiother Oncol"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1200\/JCO.2011.38.4099","article-title":"Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer","volume":"30","author":"Gillison","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00405-015-3728-0","article-title":"Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status","volume":"273","author":"Coordes","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref1471","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-43580-0_20","article-title":"Update on de-intensification and intensification studies in HPV","volume":"206","author":"Mehanna","year":"2017","journal-title":"Recent Results Cancer Res"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/cncr.26671","article-title":"Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma","volume":"118","author":"Sinha","year":"2012","journal-title":"Cancer"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"E805","DOI":"10.1002\/hed.24105","article-title":"Matted nodes: high distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer","volume":"38","author":"Vainshtein","year":"2016","journal-title":"Head Neck"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hed.23136","article-title":"Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia","volume":"34","author":"Adelstein","year":"2012","journal-title":"Head Neck"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2016.72.0748","article-title":"Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer","volume":"35","author":"Fakhry","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref1581","author":"Palma","journal-title":"A phase II randomized trial of treatment de-escalation for HPV associated oropharyngeal squamous cell carcinoma: radiotherapy vs trans-oral surgery (ORATOR 2)"},{"key":"ref1671","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","article-title":"Randomized trial of radiation therapy with weekly cisplatin or cetuximab in low-risk HPV-associated oropharyngeal cancer (TROG 12.01)\u2014a Trans-Tasman Radiation Oncology Group Study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref1361","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/cncr.32799","article-title":"Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer","volume":"126","author":"Lang Kuhs","year":"2020","journal-title":"Cancer"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/cncr.30598","article-title":"The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"123","author":"An","year":"2017","journal-title":"Cancer"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/PAS.0b013e318253a2d1","article-title":"Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials","volume":"36","author":"Jordan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"ref571","first-page":"CD010271","article-title":"De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"2","author":"Masterson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2016.72.0748","article-title":"Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer","volume":"35","author":"Fakhry","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref1801","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1200\/JCO.2014.55.1937","article-title":"Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma","volume":"32","author":"Fakhry","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref201","first-page":"108","article-title":"Multisite HPV16\/18 vaccine efficacy against cervical, anal, and oral HPV infection","volume":"108","author":"Beachler","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","article-title":"Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States","volume":"36","author":"Chaturvedi","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","article-title":"HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis","volume":"15","author":"Ndiaye","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/lary.23900","article-title":"Margin mapping in transoral surgery for head and neck cancer","volume":"123","author":"Hinni","year":"2013","journal-title":"Laryngoscope"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2019.10.011","article-title":"Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification","volume":"144","author":"Huang","year":"2020","journal-title":"Radiother Oncol"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/PAS.0b013e318253a2d1","article-title":"Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials","volume":"36","author":"Jordan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1748-717X-8-21","article-title":"Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century","volume":"8","author":"Garden","year":"2013","journal-title":"Radiat Oncol"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.2012.46.7746","article-title":"Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?","volume":"31","author":"Quon","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"138469","DOI":"10.4061\/2011\/138469","article-title":"Ancillary studies in determining human papillomavirus status of squamous cell carcinoma of the oropharynx: a review","volume":"2011","author":"Cantley","year":"2011","journal-title":"Pathol Res Int"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.19.00370","article-title":"Evolution of the oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals","volume":"37","author":"Tota","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.19.00463","article-title":"Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma","volume":"37","author":"Ma","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"e0203403","DOI":"10.1371\/journal.pone.0203403","article-title":"Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer","volume":"13","author":"LeConte","year":"2018","journal-title":"PLoS One"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.prro.2017.02.002","article-title":"Radiation therapy for oropharyngeal squamous cell carcinoma: executive summary of an ASTRO evidence-based clinical practice guideline","volume":"7","author":"Sher","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/cncr.31338","article-title":"Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"124","author":"Chera","year":"2018","journal-title":"Cancer"},{"key":"ref1111","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.2019.10508","article-title":"Prevalence of oral HPV infection in unvaccinated men and women in the United States, 2009-2016","volume":"322","author":"Chaturvedi","year":"2019","journal-title":"JAMA"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cncr.30954","article-title":"Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: findings from a phase 2 trial","volume":"124","author":"Hegde","year":"2018","journal-title":"Cancer"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/cncr.32652","article-title":"Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status","volume":"126","author":"Fullerton","year":"2020","journal-title":"Cancer"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.20.00056","article-title":"De-escalation after DE-ESCALATE and RTOG 1016: a Head and Neck Cancer InterGroup Framework for future de-escalation studies","volume":"38","author":"Mehanna","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.prro.2017.02.002","article-title":"Radiation therapy for oropharyngeal squamous cell carcinoma: executive summary of an ASTRO evidence-based clinical practice guideline","volume":"7","author":"Sher","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"ref1101","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","article-title":"Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States","volume":"36","author":"Chaturvedi","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref1821","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1748-717X-8-21","article-title":"Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century","volume":"8","author":"Garden","year":"2013","journal-title":"Radiat Oncol"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial","volume":"28","author":"Rischin","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1470-2045(17)30246-2","article-title":"Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study","volume":"18","author":"Chen","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref1371","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/cncr.25033","article-title":"Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience","volume":"116","author":"Singhi","year":"2010","journal-title":"Cancer"},{"key":"ref1681","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semradonc.2012.03.003","article-title":"Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer","volume":"22","author":"Mehra","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States","volume":"26","author":"Chaturvedi","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref511","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1200\/JCO.2014.55.1937","article-title":"Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma","volume":"32","author":"Fakhry","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref1841","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/20\/3\/article-p224.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/20\/3\/article-p224.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T18:51:39Z","timestamp":1700333499000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/20\/3\/article-p224.xml"}},"subtitle":["Featured Updates to the NCCN Guidelines"],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":184,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2022.0016","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}